Advent Venture Partners, a European venture capital firm, has formed a new company to acquire speciality pharmaceutical prescription products, headed by former Roche, Elan and Xenova veteran Geoff McMillan.
Deep Dive: Why Asia-Pacific private equity is shifting from growth to control
22 hours ago · 10 mins read
TPG targets Q4 close for latest flagship and healthcare fund
29 October 2026 · 2 mins read
Blue Owl's latest GP stakes fund close may slip to Q1 2027
29 October 2026 · 3 mins read
The largest funds take a growing share of total PE fundraising
29 October 2026 · 2 mins read
Side Letter: Mid-alignment
29 October 2026 · 3 mins read
Side Letter: Software stress
28 October 2026 · 3 mins read
Ardian bets on the ‘power of live’ in latest buyout fund
28 October 2026 · 3 mins read
